MyFinsight
Home
Blog
About
Cash
$8,296,296
(191.12%↑ Y/Y)
Prepaid expenses and
other current assets
$497,029
(8.63%↑ Y/Y)
Property and equipment,
net
$81,929
(-66.02%↓ Y/Y)
Deferred offering costs,
non-current
$68,745
Total current assets
$8,793,325
(165.87%↑ Y/Y)
Total other assets
$150,674
(-37.50%↓ Y/Y)
Total assets
$8,943,999
(152.05%↑ Y/Y)
Total liabilities,
mezzanine equity, and...
$8,943,999
(152.05%↑ Y/Y)
Total shareholders
equity
$8,082,524
(269.95%↑ Y/Y)
Total current
liabilities
$861,475
(-36.83%↓ Y/Y)
Accumulated deficit
-$119,507,698
(-7.88%↓ Y/Y)
Accumulated other
comprehensive loss
-$594,681
(-3.69%↓ Y/Y)
Additional paid-in capital
$128,145,545
(12.90%↑ Y/Y)
Accounts payable
$682,794
(-34.41%↓ Y/Y)
Accrued expenses and
other current...
$151,931
(-31.82%↓ Y/Y)
Due to related
parties
$26,750
(-73.22%↓ Y/Y)
Common stock, 0.01 par
value, 100,000,000...
$39,358
(30.07%↑ Y/Y)
Back
Back
Balance Sheet
Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (ENVB)
source: myfinsight.com